Profile | GDS5420 / 227302_s_at |
Title | Psoriasis response to brodalumab: dose response and time course |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM1296094 | A_lesional_pre-dose | 1916 | 89 |
GSM1296119 | B_lesional_pre-dose | 1152.97 | 82 |
GSM1296076 | C_lesional_pre-dose | 502.25 | 69 |
GSM1296092 | D_lesional_pre-dose | 1621.77 | 86 |
GSM1296103 | E_lesional_pre-dose | 2187.13 | 90 |
GSM1296078 | F_lesional_pre-dose | 428.05 | 66 |
GSM1296107 | G_lesional_pre-dose | 1154.5 | 82 |
GSM1296109 | H_lesional_pre-dose | 1970.83 | 89 |
GSM1296080 | I_lesional_pre-dose | 2814.44 | 93 |
GSM1296090 | J_lesional_pre-dose | 1413.51 | 84 |
GSM1296074 | K_lesional_pre-dose | 726.06 | 74 |
GSM1296111 | L_lesional_pre-dose | 1013.48 | 80 |
GSM1296099 | M_lesional_pre-dose | 1650.49 | 87 |
GSM1296086 | O_lesional_pre-dose | 1720.12 | 87 |
GSM1296117 | P_lesional_pre-dose | 885.93 | 77 |
GSM1296113 | Q_lesional_pre-dose | 876.43 | 77 |
GSM1296096 | R_lesional_pre-dose | 1629.5 | 86 |
GSM1296105 | S_lesional_pre-dose | 1934.91 | 89 |
GSM1296098 | T_lesional_pre-dose | 2300.32 | 91 |
GSM1296101 | U_lesional_pre-dose | 1994.78 | 89 |
GSM1296121 | V_lesional_pre-dose | 1238.12 | 83 |
GSM1296088 | W_lesional_pre-dose | 2289.75 | 91 |
GSM1296082 | X_lesional_pre-dose | 1354.7 | 83 |
GSM1296115 | Y_lesional_pre-dose | 949.36 | 78 |
GSM1296084 | Z_lesional_pre-dose | 2086.01 | 90 |
GSM1296072 | B_lesional_day8 | 1254.3 | 83 |
GSM1296069 | L_lesional_day8 | 1000.06 | 80 |
GSM1296071 | P_lesional_day8 | 1280.58 | 84 |
GSM1296070 | Y_lesional_day8 | 952.19 | 79 |
GSM1296073 | V_lesional_day8 | 930.68 | 78 |
GSM1296034 | A_lesional_day15 | 2807.44 | 94 |
GSM1296041 | G_lesional_day15 | 832.62 | 76 |
GSM1296035 | R_lesional_day15 | 1952.33 | 89 |
GSM1296038 | U_lesional_day15 | 1864.07 | 88 |
GSM1296047 | B_lesional_day15 | 1310.59 | 84 |
GSM1296039 | E_lesional_day15 | 978.08 | 79 |
GSM1296042 | H_lesional_day15 | 949.12 | 79 |
GSM1296043 | L_lesional_day15 | 1062.16 | 80 |
GSM1296037 | M_lesional_day15 | 2305.53 | 91 |
GSM1296046 | P_lesional_day15 | 1096.73 | 81 |
GSM1296044 | Q_lesional_day15 | 1164.93 | 82 |
GSM1296045 | Y_lesional_day15 | 1031.09 | 80 |
GSM1296025 | C_lesional_day15 | 1542.11 | 85 |
GSM1296033 | D_lesional_day15 | 2005.44 | 89 |
GSM1296027 | I_lesional_day15 | 3052.66 | 94 |
GSM1296032 | J_lesional_day15 | 2438.5 | 92 |
GSM1296024 | K_lesional_day15 | 1497.73 | 85 |
GSM1296031 | W_lesional_day15 | 2404.82 | 92 |
GSM1296028 | X_lesional_day15 | 2447.39 | 92 |
GSM1296029 | Z_lesional_day15 | 2327.77 | 91 |
GSM1296026 | F_lesional_day15 | 988.42 | 79 |
GSM1296030 | O_lesional_day15 | 2726.83 | 92 |
GSM1296040 | S_lesional_day15 | 2249.41 | 91 |
GSM1296036 | T_lesional_day15 | 2165.5 | 91 |
GSM1296048 | V_lesional_day15 | 1130.79 | 81 |
GSM1296059 | A_lesional_day43 | 2501.97 | 92 |
GSM1296066 | G_lesional_day43 | 934.4 | 78 |
GSM1296060 | R_lesional_day43 | 1531.68 | 86 |
GSM1296063 | U_lesional_day43 | 1153.08 | 81 |
GSM1296064 | E_lesional_day43 | 1045.05 | 80 |
GSM1296067 | H_lesional_day43 | 1558.96 | 87 |
GSM1296062 | M_lesional_day43 | 2486.63 | 92 |
GSM1296068 | Q_lesional_day43 | 1188.3 | 82 |
GSM1296050 | C_lesional_day43 | 929.96 | 78 |
GSM1296057 | D_lesional_day43 | 1752.5 | 88 |
GSM1296052 | I_lesional_day43 | 3031.2 | 94 |
GSM1296054 | J_lesional_day43 | 2570.01 | 93 |
GSM1296049 | K_lesional_day43 | 1121.62 | 81 |
GSM1296055 | W_lesional_day43 | 1829.67 | 88 |
GSM1296053 | X_lesional_day43 | 3030.24 | 94 |
GSM1296058 | Z_lesional_day43 | 2351.15 | 91 |
GSM1296051 | F_lesional_day43 | 756.57 | 75 |
GSM1296056 | O_lesional_day43 | 1456.27 | 84 |
GSM1296065 | S_lesional_day43 | 1342.18 | 84 |
GSM1296061 | T_lesional_day43 | 2464.53 | 92 |
GSM1296095 | A_non-lesional_pre-dose | 1378.37 | 84 |
GSM1296120 | B_non-lesional_pre-dose | 1278.86 | 83 |
GSM1296077 | C_non-lesional_pre-dose | 1465.72 | 85 |
GSM1296093 | D_non-lesional_pre-dose | 2489.72 | 92 |
GSM1296104 | E_non-lesional_pre-dose | 1460.4 | 85 |
GSM1296079 | F_non-lesional_pre-dose | 1142.47 | 81 |
GSM1296108 | G_non-lesional_pre-dose | 1461.61 | 85 |
GSM1296110 | H_non-lesional_pre-dose | 1578.1 | 87 |
GSM1296081 | I_non-lesional_pre-dose | 3642.52 | 95 |
GSM1296091 | J_non-lesional_pre-dose | 1759.75 | 87 |
GSM1296075 | K_non-lesional_pre-dose | 697.34 | 74 |
GSM1296112 | L_non-lesional_pre-dose | 1230.98 | 83 |
GSM1296100 | M_non-lesional_pre-dose | 2104.64 | 90 |
GSM1296087 | O_non-lesional_pre-dose | 2904.64 | 93 |
GSM1296118 | P_non-lesional_pre-dose | 1276.5 | 83 |
GSM1296114 | Q_non-lesional_pre-dose | 1104.47 | 81 |
GSM1296097 | R_non-lesional_pre-dose | 1646.98 | 86 |
GSM1296106 | S_non-lesional_pre-dose | 1514.28 | 86 |
GSM1296102 | U_non-lesional_pre-dose | 2305.9 | 92 |
GSM1296122 | V_non-lesional_pre-dose | 1355.57 | 84 |
GSM1296089 | W_non-lesional_pre-dose | 2547.72 | 93 |
GSM1296083 | X_non-lesional_pre-dose | 3031.52 | 94 |
GSM1296116 | Y_non-lesional_pre-dose | 1136.68 | 82 |
GSM1296085 | Z_non-lesional_pre-dose | 2656.4 | 93 |